Back
Akero Therapeutics Vs. Annovis Bio Industry Stock Comparison
Buy
73
AKRO
Akero Therapeutics
Last Price:
28.07
Seasonality Move:
-3.65%
Sell
12
ANVS
Annovis Bio
Last Price:
8.64
Seasonality Move:
-18.77%
Buy
73
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $28.07. The Score for AKRO is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
12
Annovis Bio (ANVS)
is a Sell
Is Annovis Bio a Buy, Sell or Hold?
- The current Annovis Bio [ANVS] share price is $8.47. The Score for ANVS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- ANVS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $28.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANVS Stock Price Chart
What is Annovis Bio's stock price today?
-
The Annovis Bio share price today is $8.47
The current trend is relatively stagnant and ANVS is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 62.09 | Buy |
| Chaikin Money Flow: | 623991 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.82 - 27.3) | Buy |
| Bollinger Bands (100): | (21.03 - 26.75) | Buy |
ANVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 48.53 | Sell |
| Chaikin Money Flow: | -179716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.13 - 9.15) | Sell |
| Bollinger Bands (100): | (6.06 - 10.38) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.89 | Buy |
| 20-day SMA: | 26.7 | Buy |
| 50-day SMA: | 26.3 | Buy |
| 200-day SMA: | 23.5 | Buy |
| 8-day EMA: | 27.15 | Buy |
| 20-day EMA: | 26.65 | Buy |
| 50-day EMA: | 25.83 | Buy |
| 200-day EMA: | 25.59 | Buy |
ANVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.41 | Buy |
| 20-day SMA: | 8.55 | Sell |
| 50-day SMA: | 9.25 | Sell |
| 200-day SMA: | 9.76 | Sell |
| 8-day EMA: | 8.43 | Buy |
| 20-day EMA: | 8.51 | Sell |
| 50-day EMA: | 8.73 | Sell |
| 200-day EMA: | 9.46 | Sell |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.
Annovis Bio Earnings Growth & ANVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Annovis Bio Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||